R

Revmatologie s.r.o. | Brno, Czech Republic

Research site

(Unclaimed)

Location

Halasovo nám. 1, Brno, Brno-město, Czech Republic

Site insights

Top conditions

Top treatments

Apremilast

Tofacitinib

IPP-201101

Olokizumab

BIIB059

Litifilimab

Methotrexate

Adalimumab

RTX-GRT7039

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 17 total trials

A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus (EMERALD)

The primary objective of this study is to evaluate the long-term safety and tolerability of litifilimab in participants with active systemic lupus er...

Invitation-only

Systemic Lupus Erythematosus (SLE)

Drug: Litifilimab-matching placebo

Drug: Litifilimab

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus (TOPAZ-2)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). T...

Enrolling

Lupus Erythematosus, Systemic

Drug: Placebo

Drug: Litifilimab

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections...

Active, not recruiting

Osteoarthritis

Drug: RTX-GRT7039

Drug: Placebo